Dr. Alexandra Thomas, MD
Claim this profileWake Forest Baptist Comprehensive Cancer Center
Studies Breast Cancer
Studies Tumors
7 reported clinical trials
23 drugs studied
Area of expertise
1Breast Cancer
HER2 negative
Stage IV
ER negative
2Tumors
Stage IV
HER2 negative
ER positive
Affiliated Hospitals
Clinical Trials Alexandra Thomas, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
More about Alexandra Thomas, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Alexandra Thomas, MD has experience with
- Near-Complete Estrogen Deprivation Therapy
- Amcenestrant + Abemaciclib
- Amcenestrant + Letrozole
- Cemiplimab
- Cemiplimab Plus REGN3767
- Oral Paclitaxel + Encequidar + Dostarlimab (TSR-042) + Carboplatin With Or Without Trastuzumab
Breakdown of trials Alexandra Thomas, MD has run
Breast Cancer
Tumors
Breast cancer
Cancer
Cardiovascular Complications
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexandra Thomas, MD specialize in?
Alexandra Thomas, MD focuses on Breast Cancer and Tumors. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are Stage IV.
Is Alexandra Thomas, MD currently recruiting for clinical trials?
Yes, Alexandra Thomas, MD is currently recruiting for 4 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Alexandra Thomas, MD has studied deeply?
Yes, Alexandra Thomas, MD has studied treatments such as Near-Complete Estrogen Deprivation Therapy, Amcenestrant + Abemaciclib, Amcenestrant + Letrozole.
What is the best way to schedule an appointment with Alexandra Thomas, MD?
Apply for one of the trials that Alexandra Thomas, MD is conducting.
What is the office address of Alexandra Thomas, MD?
The office of Alexandra Thomas, MD is located at: Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest Baptist Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.